Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://kalerche546198.bloguetechno.com/tirzepatide-a-new-frontier-in-diabetes-treatment-76998136